Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3064772rdf:typepubmed:Citationlld:pubmed
pubmed-article:3064772lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:3064772lifeskim:mentionsumls-concept:C1521808lld:lifeskim
pubmed-article:3064772lifeskim:mentionsumls-concept:C0678257lld:lifeskim
pubmed-article:3064772lifeskim:mentionsumls-concept:C1578536lld:lifeskim
pubmed-article:3064772lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:3064772pubmed:issue6Alld:pubmed
pubmed-article:3064772pubmed:dateCreated1989-3-23lld:pubmed
pubmed-article:3064772pubmed:abstractTextAn account of the criteria for protocol allocation and of the various treatments in the DBCG programme is given together with some numerical representations. Furthermore the article explains how the DBCG programme has been run, including its randomization. Finally there is a description of the calculation of recurrence-free survival and survival. It is concluded that in the nation-wide programme there are only minor methodological errors, and that the conclusions based on the therapeutic outcome of the different therapies are reliable.lld:pubmed
pubmed-article:3064772pubmed:languageenglld:pubmed
pubmed-article:3064772pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3064772pubmed:citationSubsetIMlld:pubmed
pubmed-article:3064772pubmed:statusMEDLINElld:pubmed
pubmed-article:3064772pubmed:issn0284-186Xlld:pubmed
pubmed-article:3064772pubmed:authorpubmed-author:MouridsenH...lld:pubmed
pubmed-article:3064772pubmed:authorpubmed-author:AndersenK WKWlld:pubmed
pubmed-article:3064772pubmed:issnTypePrintlld:pubmed
pubmed-article:3064772pubmed:volume27lld:pubmed
pubmed-article:3064772pubmed:ownerNLMlld:pubmed
pubmed-article:3064772pubmed:authorsCompleteYlld:pubmed
pubmed-article:3064772pubmed:pagination627-47lld:pubmed
pubmed-article:3064772pubmed:dateRevised2009-5-12lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:meshHeadingpubmed-meshheading:3064772-...lld:pubmed
pubmed-article:3064772pubmed:year1988lld:pubmed
pubmed-article:3064772pubmed:articleTitleDanish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer.lld:pubmed
pubmed-article:3064772pubmed:affiliationDBCG Secretariat, Finsen Institute, Rigshospitalet, Copenhagen, Denmark.lld:pubmed
pubmed-article:3064772pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3064772pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3064772pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3064772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3064772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3064772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3064772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3064772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3064772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3064772lld:pubmed